<SEC-DOCUMENT>0001274737-25-000023.txt : 20250505
<SEC-HEADER>0001274737-25-000023.hdr.sgml : 20250505
<ACCEPTANCE-DATETIME>20250505080154
ACCESSION NUMBER:		0001274737-25-000023
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250505
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250505
DATE AS OF CHANGE:		20250505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXAGEN INC.
		CENTRAL INDEX KEY:			0001274737
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39049
		FILM NUMBER:		25910964

	BUSINESS ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081
		BUSINESS PHONE:		(760) 560-1501

	MAIL ADDRESS:	
		STREET 1:		1261 LIBERTY WAY
		CITY:			VISTA
		STATE:			CA
		ZIP:			92081

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXAGEN DIAGNOSTICS INC
		DATE OF NAME CHANGE:	20031230
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exdx-20250505.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:62702475-3a01-420c-9ee7-2133a4b68fae,g:c1be066e-c18c-460d-8d8c-314e76c9d016,d:5956fbce74624fafa959f42c44bc3372-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>exdx-20250505</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-23">0001274737</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-24">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="exdx-20250505.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001274737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-05-05</xbrli:startDate><xbrli:endDate>2025-05-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5956fbce74624fafa959f42c44bc3372_1"></div><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934 </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May&#160;5, 2025</ix:nonNumeric> </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">EXAGEN INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.535%"><tr><td style="width:1.0%"/><td style="width:32.544%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.118%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.046%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.546%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39049</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">20-0434866</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">1261 Liberty Way</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Vista</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92081</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">760</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">560-1501</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code) </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report) </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.071%"><tr><td style="width:1.0%"/><td style="width:2.331%"/><td style="width:0.1%"/><td style="width:0.0%"/><td style="width:0.163%"/><td style="width:0.0%"/><td style="width:1.0%"/><td style="width:95.306%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.679%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.959%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.682%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Symbol(s)</span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">on which registered</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">XGN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric>  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#9744; </span></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. Results of Operations and Financial Condition. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-21">May&#160;5, 2025</ix:nonNumeric>, the Company reported its financial results for the three months ended March&#160;31, 2025. A copy of the press release issued by the Company is furnished as Exhibit 99.1 to this report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information furnished with Item 2.02 of this report, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filings under the Exchange Act or under the Securities Act of 1933, as amended, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:86.103%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="q12025exagenearningspressr.htm">Press Release dated May 5, 2025</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.220%"><tr><td style="width:1.0%"/><td style="width:43.108%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.652%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.978%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.947%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EXAGEN INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="6" style="padding:0 1pt"><div><span><br/></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-22">May&#160;5, 2025</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jeffrey G. Black</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey G. Black</span></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q12025exagenearningspressr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i4db9223d77124a60ac9328e6ae9ce0c0_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:8pt"><img alt="image.jpg" src="image.jpg" style="height:52px;margin-bottom:5pt;vertical-align:text-bottom;width:189px"></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:115%">Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume </font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">May&#160;5, 2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Carlsbad, Calif., &#8211; Exagen Inc. (Nasdaq&#58; XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March&#160;31, 2025, and recent corporate updates.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.133%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except ASP data)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,498&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58.9&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.6&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating expenses </font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,488&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,601&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,365)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,003)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,752)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,360)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,508)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,992)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,194&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,267&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trailing-twelve-month average selling price (ASP)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">419&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">377&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:115%">Q1 2025 Highlights and Recent Corporate Updates&#58;</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Delivered record total revenue of $15.5 million on the strength of continued ASP expansion and AVISE CTD test volume growth.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Expanded AVISE CTD trailing twelve-month ASP to $419, an increase of $42 per test over the first quarter of 2024. </font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Enhanced AVISE CTD offering with commercial launch of new systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) biomarkers&#59; expected reimbursement in line with initial estimates of $90 per test.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.53pt">Ended the first quarter of 2025 with cash, cash equivalents and restricted cash of $11.2 million, with an accounts receivable balance of $14.7 million, driven by the company's strategy to hold claims in the first quarter to maximize reimbursement. Following the initial release of held claims in April 2025, combined cash, cash equivalents and accounts receivable are projected to be approximately $28 million as of April 30, 2025.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Closed a senior secured credit facility with Perceptive Advisors on April 25, 2025, with $25 million funded at closing to refinance existing debt and extend maturity&#59; potential additional borrowing capacity for minimally dilutive growth capital available.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:12.03pt">Published T-cell manuscript in a peer-reviewed journal, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:125%">Frontiers in Immunology, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">detailing clinical benefit of new SLE biomarkers.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:13.8pt">Presented research on biomarkers for early detection of kidney damage at the 7th Annual Chronic Kidney Disease Drug Development Summit in Boston.</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:13.8pt">Initiated commercial expansion with first wave of new sales territories identified.</font></div><div style="padding-left:18pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">2025 Guidance&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company expects 2025 full-year revenue of at least $65 million and anticipates being on-track to deliver positive adjusted EBITDA in the fourth quarter of 2025.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Conference Call</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A conference call to review first quarter 2025 financial results and to provide a business update is scheduled for today, May 5, 2025 at 8&#58;30 a.m. ET (5&#58;30 a.m. PT). Interested parties may access the conference call by dialing (201) 389-0918 (U.S.) or (877) 407-0890 (international). Additionally, a link to a live webcast of the call will be available in the Investor Relations section of Exagen's website at investors.exagen.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Participants are asked to join a few minutes prior to the call to register for the event. A replay of the conference call will be available until May 19, 2025. Interested parties may access the replay by dialing (201) 612-7415 (U.S.) or (877) 660-6853 (international) using passcode 13753132. A link to the replay of the webcast will also be available in the Investor Relations section of Exagen's website.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Use of Non-GAAP Financial Measures (UNAUDITED)</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In addition to the financial results prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release contains the metric adjusted EBITDA, which is not calculated in accordance with GAAP and is a non-GAAP financial measure. Adjusted EBITDA excludes from net loss interest income (expense), income tax expense (benefit), depreciation and amortization expense, stock-based compensation expense and other expenses or income that management believes are not representative of the company&#8217;s operations. Such items could have a significant impact on the calculation of GAAP net loss.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Exagen uses adjusted EBITDA internally because the company believes these metrics provide useful supplemental information in assessing its operating performance reported in accordance with GAAP. Exagen believes adjusted EBITDA may enhance an evaluation of our operating performance because it excludes the impact of prior decisions made about capital investment, financing, investing and certain expenses the company believes are not indicative of our ongoing performance. However, this non-GAAP </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">financial measure may be different from non-GAAP financial measures used by other companies, even when the same or similarly titled terms are used to identify such measures, limiting their usefulness for comparative purposes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">This non-GAAP financial measure is not meant to be considered in isolation or used as a substitute for net loss reported in accordance with GAAP, should be considered in conjunction with our financial information presented in accordance with GAAP, has no standardized meaning prescribed by GAAP, is unaudited, and is not prepared under any comprehensive set of accounting rules or principles. In addition, from time to time in the future, there may be other items that Exagen may exclude for purposes of these non-GAAP financial measures, and the company may in the future cease to exclude items that it has historically excluded for purposes of these non-GAAP financial measures. Likewise, Exagen may determine to modify the nature of adjustments to arrive at these non-GAAP financial measures. Because of the non-standardized definitions of non-GAAP financial measures, the non-GAAP financial measure as used by the company in this press release and the accompanying reconciliation table have limits in their usefulness to investors and may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by other companies. Accordingly, investors should not place undue reliance on non-GAAP financial measures.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A reconciliation of net loss to non-GAAP adjusted EBITDA is provided in the financial schedules that are part of this press release.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">About Exagen</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Exagen Inc. (Nasdaq&#58; XGN) is a leading provider of autoimmune diagnostics, committed to transforming care for patients with chronic and debilitating autoimmune conditions. Based in San Diego County, California, Exagen&#8217;s mission is to provide clarity in autoimmune disease decision making and improve clinical outcomes through its innovative testing portfolio. The company&#8217;s flagship product, AVISE&#174; CTD, enables clinicians to more effectively diagnose complex autoimmune conditions such as lupus, rheumatoid arthritis, and Sj&#246;gren&#8217;s syndrome earlier and with greater accuracy. Exagen&#8217;s laboratory specializes in the testing of rheumatic diseases, delivering precise and timely results, supported by a full suite of AVISE&#174;-branded tests for disease diagnosis, prognosis, and monitoring. With a focus on research, innovation, education, and patient-centered care, Exagen is dedicated to addressing the ongoing challenges of autoimmune disease management.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">For more information, please visit Exagen.com or follow &#64;ExagenInc on X.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Exagen cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on Exagen&#8217;s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding&#58; Exagen&#8217;s goals, strategies, positioning, and ambitions&#59; evaluations and judgments regarding financial results and the potential implications of those results, potential future financial and business performance, including any improvements to adjusted EBITDA, ASP, net loss and potential profitability and&#47;or Exagen&#8217;s ability obtain additional funding pursuant to its secured credit facility with Perceptive Advisors (which is subject to milestones and conditions)&#59; the potential utility and effectiveness of Exagen&#8217;s services and testing solutions&#59; potential shareholder value and growth and full-year 2025 </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">guidance. The inclusion of forward-looking statements should not be regarded as a representation by Exagen that any of its plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Exagen&#8217;s business, including, without limitation&#58; delays in reimbursement and coverage decisions from Medicare and third-party payors and interactions with regulatory authorities, and delays in ongoing and planned clinical trials involving its tests&#59; the potential effects of inflation and tariffs on Exagen&#8217;s margins&#59; and changes in laws and regulations related to Exagen&#8217;s regulatory requirements. Exagen&#8217;s commercial success depends upon attaining and maintaining significant market acceptance of its testing products among rheumatologists, patients, third-party payors and others in the medical community&#59; Exagen&#8217;s ability to successfully execute on its business strategies&#59; third-party payors not providing coverage and adequate reimbursement for Exagen&#8217;s testing products, including Exagen&#8217;s ability to collect on funds due&#59; Exagen&#8217;s ability to obtain and maintain intellectual property protection for its testing products&#59; regulatory developments affecting Exagen&#8217;s business&#59; and other risks described in Exagen&#8217;s prior press releases and Exagen&#8217;s filings with the Securities and Exchange Commission (SEC), including under the heading &#8220;Risk Factors&#8221; in Exagen&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 11, 2025 and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Exagen undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Ryan Douglas</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Exagen Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ir&#64;exagen.com </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">760.560.1525</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4db9223d77124a60ac9328e6ae9ce0c0_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exagen Inc.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.628%"><tr><td style="width:1.0%"></td><td style="width:65.335%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.819%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,498&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of revenue</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,375&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,817&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gross margin</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,123&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,598&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,204&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,542&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development expenses</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,284&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,059&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,488&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,601&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,365)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,003)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(545)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(549)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">192&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,752)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,360)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.20)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.19)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted-average number of shares used to compute net loss per share, basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,557,390&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,944,438&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4db9223d77124a60ac9328e6ae9ce0c0_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exagen Inc.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Condensed Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2025</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,194&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22,036&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14,728&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,835&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,583&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,584&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,505&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,455&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,025&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,283&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,168&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,401&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">596&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total assets</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,294&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,689&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liabilities and Stockholders' Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,509&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,137&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued and other current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,948&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,117&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">876&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">733&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, current</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,127&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,096&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings, current</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,535&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">423&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,995&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,506&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Borrowings, non-current, net of discounts and debt issuance costs</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,405&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,822&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,369&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,664&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities, non-current</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33,891&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35,149&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 5)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders' equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock, $0.001 par value&#59; 10,000,000 shares authorized, no shares issued or outstanding as of March 31, 2025 and December 31, 2024</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock, $0.001 par value&#59; 200,000,000 shares authorized as of March 31, 2025 and December 31, 2024&#59; 17,950,033 and 17,640,328 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Additional paid-in capital</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304,468&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303,853&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(298,083)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(294,331)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total stockholders' equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,403&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,540&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total liabilities and stockholders' equity</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,294&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44,689&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i4db9223d77124a60ac9328e6ae9ce0c0_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exagen Inc.</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliation of Non-GAAP Financial Measures (UNAUDITED)</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The table below presents the reconciliation of adjusted EBITDA, which is a non-GAAP financial measure. See &#34;Use of Non-GAAP Financial Measures (UNAUDITED)&#34; above for further information regarding the company's use of non-GAAP financial measures.</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.301%"><tr><td style="width:1.0%"></td><td style="width:63.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Adjusted EBITDA</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,752)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3,360)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other (income) expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(158)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(192)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">545&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">549&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization expense</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">458&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">417&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">553&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjusted EBITDA (Non-GAAP)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,508)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,992)</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-top:9pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exdx-20250505.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:62702475-3a01-420c-9ee7-2133a4b68fae,g:c1be066e-c18c-460d-8d8c-314e76c9d016-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:exdx="http://www.exagen.com/20250505" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exagen.com/20250505">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20250505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exdx-20250505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.exagen.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>exdx-20250505_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:62702475-3a01-420c-9ee7-2133a4b68fae,g:c1be066e-c18c-460d-8d8c-314e76c9d016-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ad0c2f91-ad4c-4c72-9153-94a8b68e847e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1753ebda-fda9-4eb2-886b-3cb94772e8fb_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2bbc7062-e85a-4d12-9d0c-a9ffa7edf841_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4aa66138-932b-4d1a-9ae8-17b7c97742ab_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f4feb433-c9b8-4527-b3de-b26515a55e86_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_4992f3dd-ed0d-4fc7-a7cb-573896ec67ba_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b360d4de-0289-4caf-9b06-c4c9f46516c2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_349880a5-933a-430f-a28d-07d15c1a6231_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ad933173-82f1-460c-ad39-1f45b94a5e37_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5576bcc3-3903-4a40-ac3c-b174a4f4245f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1417d534-5984-4176-b2c7-41ab09a8b6f5_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_12214f7b-6cd7-4725-a975-610b78a5939e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_e589eaaa-d255-4620-b2d1-eef3291dc517_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_54497bfe-1f55-4b84-9b39-528555df7325_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_65344b5d-5745-448f-a8ac-5b0aa66f2631_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_7acf8015-e633-4ad8-ae1c-ab2deeaf63ca_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_553553b4-464d-481f-97a5-1f469028e7a0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0d9a87de-db51-4f60-a024-607226147200_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_90179ccf-e522-4923-adea-b8c0737e5fbf_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_aca10fcd-1b39-4a52-8055-6b54ed605443_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f47cfa47-c8a1-4fe0-a1f2-bbef914e8045_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a23dece9-9a93-4182-9e62-cd02d095936f_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>exdx-20250505_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:62702475-3a01-420c-9ee7-2133a4b68fae,g:c1be066e-c18c-460d-8d8c-314e76c9d016-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.exagen.com/role/Cover" xlink:type="simple" xlink:href="exdx-20250505.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.exagen.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_00d4e50f-abf9-4d74-b90f-c4324a45b394" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_DocumentType_00d4e50f-abf9-4d74-b90f-c4324a45b394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8b93ded7-95ed-47fe-aacf-81ab60cb5ee5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_DocumentPeriodEndDate_8b93ded7-95ed-47fe-aacf-81ab60cb5ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d1b64bf1-21a4-4b7d-86c0-4d9429f29ff3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityRegistrantName_d1b64bf1-21a4-4b7d-86c0-4d9429f29ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8a16e281-3be5-46e3-ad47-8e26570a6183" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8a16e281-3be5-46e3-ad47-8e26570a6183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e1d7bb92-08e2-4ba4-8e33-b8a99e3e460e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityFileNumber_e1d7bb92-08e2-4ba4-8e33-b8a99e3e460e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6b444946-c03b-448e-89ee-4c81ff822cbd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityTaxIdentificationNumber_6b444946-c03b-448e-89ee-4c81ff822cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_1838618e-0d96-4aa0-b3ac-abda0ae77499" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityAddressAddressLine1_1838618e-0d96-4aa0-b3ac-abda0ae77499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_956177ac-c112-4f93-9f63-1ecb6f32fec7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityAddressCityOrTown_956177ac-c112-4f93-9f63-1ecb6f32fec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f5fc0e50-460c-4a49-b2b0-05f54112bab9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityAddressStateOrProvince_f5fc0e50-460c-4a49-b2b0-05f54112bab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_530929c6-d032-4c9f-aade-108017e44a96" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityAddressPostalZipCode_530929c6-d032-4c9f-aade-108017e44a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_85fcddd0-b174-4d64-aff2-c3add8590414" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_CityAreaCode_85fcddd0-b174-4d64-aff2-c3add8590414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_28c7709b-41d2-4f4e-86df-9ff7a1bc8999" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_LocalPhoneNumber_28c7709b-41d2-4f4e-86df-9ff7a1bc8999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_261e32bf-a21d-43b9-bb0a-fe554de274a9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_WrittenCommunications_261e32bf-a21d-43b9-bb0a-fe554de274a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_3da123af-2134-4840-ae2c-1738a401951c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_SolicitingMaterial_3da123af-2134-4840-ae2c-1738a401951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_760dc100-f185-41cb-8718-75102125310d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_PreCommencementTenderOffer_760dc100-f185-41cb-8718-75102125310d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_596085e1-cfa9-419e-9380-eef2727979d1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_596085e1-cfa9-419e-9380-eef2727979d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b0de097b-e527-4452-9bcf-6e39149f805a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_Security12bTitle_b0de097b-e527-4452-9bcf-6e39149f805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_264376bb-5626-43b9-a40b-f88ffc1d8544" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_TradingSymbol_264376bb-5626-43b9-a40b-f88ffc1d8544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b33b777c-cea4-4c4d-8c00-fb03e04c0914" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_SecurityExchangeName_b33b777c-cea4-4c4d-8c00-fb03e04c0914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f65a0496-0dd0-43db-95b9-3ba9d01352a3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityEmergingGrowthCompany_f65a0496-0dd0-43db-95b9-3ba9d01352a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b3d9043-740d-48e1-85f4-b640f4bfa1a8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_EntityCentralIndexKey_7b3d9043-740d-48e1-85f4-b640f4bfa1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_eee6dadf-8ec4-47f0-8498-4f583418b558" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d910cbbf-f399-448e-a600-08ac87b69765" xlink:to="loc_dei_AmendmentFlag_eee6dadf-8ec4-47f0-8498-4f583418b558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image.jpg
<TEXT>
begin 644 image.jpg
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M:E6@/G>B[?A2LU.X&FD=@+\_09F?#SW>1+QS8%<'(6@TEYQ.E,)$\6#;28N
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%1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXAGEN INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-0434866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1261 Liberty Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Vista<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">560-1501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">XGN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001274737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #I I5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( #I I5J2I//U[0   "L"   1
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MS2CXA7T [B^E-.\#NT$M_K\P^ ]02P,$%     @ .D"E6I^@&_"Q @  X@P
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MB^$_7G\!4$L! A0#%     @ .D"E6D;'34B5    S0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    "  Z0*5:DJ3S]>T
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #I I5J7BKL<P    !,"   +
M      "  6L/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( #I I5JJQ"(6,P$
M "("   /              "  500  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    "  Z0*5:)!Z;HJT   #X 0  &@              @ &T$0  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  Z0*5:99!YDAD!  #/
M P  $P              @ &9$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  #C$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exdx-20250505.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exagen.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="exdx-20250505.htm">exdx-20250505.htm</File>
    <File>exdx-20250505.xsd</File>
    <File>exdx-20250505_lab.xml</File>
    <File>exdx-20250505_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exdx-20250505.htm": {
   "nsprefix": "exdx",
   "nsuri": "http://www.exagen.com/20250505",
   "dts": {
    "inline": {
     "local": [
      "exdx-20250505.htm"
     ]
    },
    "schema": {
     "local": [
      "exdx-20250505.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "exdx-20250505_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exdx-20250505_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.exagen.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exdx-20250505.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exdx-20250505.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.exagen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001274737-25-000023-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001274737-25-000023-xbrl.zip
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M7#O#\0Y0Q.00B% 15; ^$LVLDZA/#C",V!?-]F(@&S\#K]?RP#"\K9JB>?@
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MVO:E,)PTR-]L?J[33[^DP>IO7J?>:7@;?[;KSAU_:]EWNW/;8)U.W6EL_KF
M@VWL^EB0"37FT:\O&E/7DDM'%$>B&%?^0M*5;+IES -4WU/PA<Q9]%BAZ*_(
ML1;A%SM;I_,$%'N#;>K<9II(.[3&3]5U\^3SF=@XCW5TZNXR:>-6GG#:*ZZ6
MIOUEF C!/L!U0\7>S0P@ ]NW S&>1&8V4OI.EQJ+F\;C4[@6'88,6$[=$G!L
MP<7?<YJ[D\NXG-5''0$YFX\NZ,_4X-)C3F4*K_!W,,$G@-W389S!0P/ ;^*'
M+T"BSJ\^,<!9_/7#VN;]]>,6@J]&2[XO!$1+>W("1O24?L\$4KM8E-LFN$SU
M?0ACL\(B@Y^6:;/7O.;G0TF1PT_(\:QFM[,>\.PIS&S/.5;B]0S$JVDU':]H
MXE4Z![XQ^U9L?_)'$BO%=*+B3DYE:98;7;F['Z766H"":(S7J7?WU)?ULK"O
MOCS9#/^G$H4=1:%;;U6B< 3&NA3@_V]CD7#*FXL?8Q$IH5@5"#PCI.9:S4X5
M"%3B]4CBY5@MVRF:>!V!;RE%(##S+2%$!(^!_^Z-^<JF]^OF54"]/VE8C9:W
MDJ]]9 !;2=:SD"S;;A1(LH[ F90B4/DHTKN[D0H^EA(^@K*W/7=W9:\"DTJR
M]@ H=H$DZPC<2"EBDO/@6Z:P&/3=;^^_7)Y70<DS@HZNY=F= D''2K*.1;(<
MJ]O= Z=40<F1!"477 UI9X"/?XA_9_*:AR)*JRCE&6%)Q[&<;K-H2>Y*O(Y$
MO-RVY;;:11.O(_ PI8A7OB1<XA;&6GHCPFM1&\$=X'+,_D9E]C>.:7_CR?G5
MIUUJI"O<>22XL^D<IFBLDJWCEZU&>U^?\URCFE]H9^[;?79;/^U.[/5;[/-]
M]'^![T+\7E$D\UGO<;Z8[G'^JO<XTU[LC=OE#=-KJ(RG3N>6W?%K[_*:N5Z;
M3?:UN><\/%'6;T_'S>AN:SK/IWOUV2(%W;K7P,E?BE""I@C:>X[=#](XI?WK
MNO=!W&<_.5[=8S".4,81BR/:SZ[21$0#  IP@0]OEG!Q0/NHQ \0:X67(K//
M__[^ZAV[^'))N^?9M6Z*,* ^"JN;V@O$[&WVK62L;M8=#Z?^#CF#NV_GF&+
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M_U[K<:7!*WZ[< 7=&@-UDED+$%"Z_-U#,- 0U8.R41S2 T0#QDK;/:16@J/
MT(C2D#/#1<B*>GNWS^"!>BLXZ' =0AFD=2I&"B[+PH -$3)SIN0@ FCL<UR)
M@-O]-%_.S#EB5)\(GM.O&'J_7BM,2_,,2;J*_,B.HL3WA,_AFGG"S>@,7ZI<
M<-44A,#E@%.9RL:@%,@8$#P9@3<9:2JAX"IX+5EGF4X9@+HD$KH.)7K:&GV#
MH-?SKNPSMB]- QV+T M;N&X@KGF831D%J';#B_,I0T@[50O*[1N^]XW?#$#
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MV ,QP*<L[AS16FAVI<^2]C2)#P2=DCSA((',&#U. '1-\H0!K89P7]M#L@5
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MNVS'J/S!'0A/CSG%6DOI[U*3(B, AG$&#PW4+EOW]O 4^ZM#V;=-KA-W/9@
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MTU'X]O\!4$L! A0#%     @ .D"E6AK0LDS0#@  OFT  !$
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$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exdx-20250505_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exdx-20250505.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001274737</identifier>
        </entity>
        <period>
            <startDate>2025-05-05</startDate>
            <endDate>2025-05-05</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-23">0001274737</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-24">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">EXAGEN INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39049</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">20-0434866</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">1261 Liberty Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Vista</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92081</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">760</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">560-1501</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">XGN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-21">2025-05-05</dei:DocumentPeriodEndDate>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-22">2025-05-05</dei:DocumentPeriodEndDate>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
